Merit Medical Systems (MMSI) Net Equity Issued and Repurchased (2010 - 2026)

Merit Medical Systems has reported Net Equity Issued and Repurchased for 17 years, with the latest figure at $1.8 million in Q2 2026.

• Quarterly Net Equity Issued and Repurchased fell 73.07% year-over-year to $1.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $12.8 million (down 74.35% YoY) and the FY2025 annual result came in at $28.2 million, down 31.03% from the prior year.
• Net Equity Issued and Repurchased declined to $1.8 million in Q2 2026 per MMSI's latest filing, from $2.8 million in the prior quarter.
• Over five years, Net Equity Issued and Repurchased peaked at $25.5 million in Q4 2024 and troughed at $1.6 million in Q2 2022.
• A 5-year average of $6.1 million and a median of $4.1 million in 2023 frame the typical range for Net Equity Issued and Repurchased.
• The sharpest annual moves came in 2024 and 2026: Net Equity Issued and Repurchased jumped 515.85% in 2024, then tumbled 78.9% in 2026.
• Over 5 years, Net Equity Issued and Repurchased stood at $13.3 million in 2022, then plunged by 68.97% to $4.1 million in 2023, then surged by 515.85% to $25.5 million in 2024, then slumped by 76.32% to $6.0 million in 2025, then plunged by 69.37% to $1.8 million in 2026.
• According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $1.8 million, $2.8 million, and $6.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.